Background How multimorbidity and socio-economic factors influence healthcare costs is unknown. Geo-demographic profiling system, Mosaic, which adds to socio-economic factors, provides the potential for an investigation of the relationship with multimorbidity, and their influence on healthcare costs.
Introduction
Mosaic segmentation is a consumer classification system designed by Experian for market research and profiling purposes.
1,2 It classifies residential postcodes on the basis of census and lifestyle characteristics obtained from a range of data sources 1, 3 and includes details on socio-economic indicators and socio-cultural behaviour with reference to the geographical location. 4 It allows the breakdown ('segmentation') of the population into smaller groups defined by individual characteristics as well as area-level 5 than those used by the usual methods of socio-demographic classification such as the Townsend Index of Deprivation, 6 to enable its use in targeted marketing, advertising and specific campaigns in populations who share similar social profiles. 7 In healthcare settings, 3, 4, 8 there is emerging research in the use of Mosaic segmentation, as potentially providing better social profiles for identifying health needs. It has been used to assess population variation in smoking, 3, 4 hospital admission for heavy alcohol consumption, 8 in identifying population clusters with lung cancer 9 and identifying influenza among neighbourhoods.
2 Local health policy developments have also begun to use Mosaic to profile their population and assess their health needs.
Extending this previous work, we investigated the potential application of Mosaic segmentation for identifying high-hospital-cost patients in an empirically chosen multimorbidity of chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF). Chronic disease multimorbidity is important in ageing populations 12 and hence provides a testable framework to illustrate the potential of Mosaic segmentation in population healthcare delivery. Both CHF and COPD are associated with high rates of hospital admissions and are major causes of disability and mortality. 13 Populations with heart failure incur great economic burden on healthcare systems, with costs exceeding those of breast and lung cancer combined. 13 The UK national estimates have also shown that CHF and COPD are associated with high hospital admission costs, 14, 15 which vary substantially worldwide, tending to be higher in the USA than in Europe and Canada. 16 CHF and COPD are individually important, but they also commonly co-occur. One study showed that 40% of patients with COPD also had CHF and that multimorbidity was associated with high healthcare utilization. 17, 18 Characteristics of the population and community may also influence their health status as well as access to services. 19 Research has suggested that socio-economic status is associated with COPD 20 and CHF 21 in terms of morbidity and mortality. There is also evidence that multiple chronic conditions are more common in deprived areas, and the interaction between multimorbidity and deprivation may add further contribution to health inequalities. 22, 23 Whilst social deprivation is one factor in increased healthcare utilization, 21, 24 few studies have examined an enhanced segmentation approach, which incorporates socio-economic factors, and multimorbidity together.
To investigate the potential use of Mosaic segmentation, we investigated the relationship between the Mosaic measure for individuals with a specified multimorbidity of COPD and CHD, and their associated hospital admissions and costs over a 3-year time period.
Methods

Design
An anonymized clinical database linking chronic disease registers and hospital data was used from adult population, aged 40 years and over, for 230 000 people registered with a general practitioner in Stoke-on-Trent.
Chronic disease registers
The database for this study covers a 3-year period between 1 January 2007 and 31 December 2009 and was based on 53 out of 57 practices in Stoke-on-Trent. All practices participate in national and local quality improvement frameworks for specific chronic diseases, such as CHF and COPD. Using the Read code classification, 25 practices develop registers for their population. All patients with a diagnosis of COPD or CHF were identified within the database registers and separated into three groups: (i) an 'index' COPD group without CHF, (ii) an 'index' CHF group without COPD and (iii) a multimorbid group with both CHF and COPD.
Linked Mosaic measure
The Mosaic segmentation measure was linked using individual patient residential post codes within the clinical database. The Mosaic profiling is drawn from the 2001 UK census, lifestyle survey, consumer credit databases, the electoral roll, shareholder registers, land registry data, council tax information, Hospital Episode Statistics (HES), the British Crime Survey, Expenditure and Food Survey and other sources. 9, 26 The current version of Mosaic classifies all consumers in the UK into one of the 61 distinct 'lifestyle types' aggregated into a set of 11 lifestyle groups which are used to describe socioeconomic and socio-cultural behaviour. 26, 27 A brief description of the 11 Mosaic groups is given in Supplementary data.
Linked hospital admissions and cost data
A unique NHS number was used to link population aged 40 years and over on COPD or CHF registers to any hospital admissions in the 3-year time period. The hospital admission data were based on HES. 28 Healthcare Resource Groups (HRGs) is used as a measure of hospital admission cost in the 3-year time period. HRGs are nationally developed and they group together treatments that are clinically similar, consume similar quantities of resources and are likely to be similar in cost. 29 All linkages were carried out prior to the construction of the study database and provision of anonymized data was made under existing service agreements.
Statistical analyses
Descriptive data are presented first by socio-demographic factors, 11 Mosaic groups and the three study groups. General linear models were used to examine the associations between age groups, gender, Mosaic groups and hospital costs in pounds sterling separately for each of the three chronic disease groups. Within the overall model, comparisons were as follows: older groups were compared with the youngest group (40-49 years for COPD and CHF patients and 40 -59 years for multimorbid patients due to small numbers in the youngest group), women were compared with men and the 10 Mosaic groups were compared with group A 'symbol of success' as reference. The model was then repeated to include the four most common Mosaic groups with the other seven groups collated into one 'other' group. This extra modelling step was used to test the hypothesis that the influence of specific and common Mosaic groups on the hospital admissions were distinct, when compared with all the other less common Mosaic groups combined. General linear models were also used to test for a linear trend in hospital costs for age group, chronic disease group (in the order of clinical severity; COPD, CHF and multimorbidity) and the four most common Mosaic groups in a possible order of deprivation (D 'ties of community', H 'blue collar enterprise', G 'municipal dependency' and I 'twilight subsistence') and in the presence of gender. A two-tailed significance level value of 5% was used with no adjustments for multiple testing, and using SPSS software version 18 for Windows.
Results
Characteristics of the study population Table 1 shows that over 75% of the multimorbid population were aged 70 years and over compared with only 45.5% of the index COPD group. There were more men than women in the index COPD group (55.2%) and multimorbid group (56.4%), but there were more women than men in the index CHF group (54.7%). The commonest Mosaic groups were D (30.4%), G (28.7%), H (10.6%) and I (9.8%). There was a variation in the distribution of the 11 Mosaic groups in the three study groups, with a higher proportion of group G (31.2%) than D (25.4%) in the multimorbid group.
Characteristics of hospital admissions and costs by study population
Of the total study population, 6095 (60.3%) patients were admitted to hospital at least once during the study period. The mean age of those admitted to hospital at least once was 71.5 years (SD ¼ 11.2) and 51.7% of them were men. The mean number of admissions in the 3-year period decreased with increasing age, but the mean total costs for the admissions increased with age ( Table 2 ).
The multimorbid group had the highest percentage of hospital admissions (72.1%) compared with patients with either index COPD (56.2%) or index CHF (66.2%) groups. In addition, the multimorbid group had the highest mean number of admissions in the 3-year time period 5.5 (SD ¼ 26.2) compared with 4.9 (SD ¼ 20.2) for the index CHF group and 3.6 (SD ¼ 9.2) for the index COPD group. The multimorbid group had the highest mean total 3-year costs per patient for hospital admissions (£4896) compared with the index CHF group (£3876) or the index COPD group (£2769), and all groups had wide standard deviations.
The proportion of each Mosaic group likely to be admitted to hospital, the mean number of hospital admissions and the mean total cost of hospitalization varied across different groups. The lowest mean number of hospital admission figures were for the smaller sized groups A and E 'urban intelligence' at 2.9 (SD ¼ 2.8 and 2.4, respectively), and the highest mean figures with a wide variation were among groups C 'suburban comfort' and I at 4.9 (SD ¼ 21.7 and 21.1, respectively).
Associations between factors and hospital admission costs within the study groups
In Table 3 , hospital admission costs reduced with increasing age in the multimorbid group; however, such differences were not statistically significant. Women with CHF and COPD multimorbidity hospital admission costs were on average The lowest total mean costs for hospital admissions were for groups E (£3609) and A (£4986) and the highest mean costs were for groups J ('grey perspectives'-£6172) and K ('rural isolation'-£6724) (Fig. 1) .
Within the multimorbid group, the mean hospital cost differences for all the other 10 Mosaic groups, compared with Mosaic group A, were not significantly higher. Compared with the reference group A, the adjusted highest cost difference was for group B (£7060, 95% CI ¼ 2£541 to £14 662) and the lowest cost difference was for group K (£2334, 95% CI ¼ 2£5500 to £10 168). We repeated the analysis by focusing on the four common Mosaic groups (D, G, H and I) and compared with all the other Mosaic groups combined as one reference group. In the multimorbid group, patients from Mosaic group I and group H had higher hospital costs than patients from other Mosaic groups, but the difference was not statistically significant.
When the linear models were repeated with only four Mosaic groups, all the study-selected factors, apart from gender, entered into the model were significantly associated with the hospital costs. Assuming a linear trend in hospital admission costs, an increase in age by a decade was significantly associated with an increase of £192 (CI ¼ £90 -£293) and change in the Mosaic group was associated with a significant increase of £158 (CI ¼ £52 -£264) in cost. More importantly, a change from the index COPD group to the index CHF group was significantly associated with an increase in the hospital admission cost of £997 (CI ¼ £806 -£1188) and was increased by a further £997 in the multimorbid group.
Discussion
Main findings of this study
Multimorbidity was the lowest among Mosaic groups A ('symbols of success') and B ('happy families') as affluent indicators of socio-economic status, and the highest among the Mosaic groups D (ties of community') and G ('municipal dependency'), which are characterized by deprived socioeconomic status. These findings are consistent with previous studies. 3, 23 Whilst there are no direct comparable studies on Mosaic segmentation, studies have shown that Mosaic group D is associated with higher alcohol hospital admissions, 8 Mosaic groups G is associated with the highest and Mosaic group A with the lowest smoking figures.
3 Overall, Mosaic group K ('rural isolation') had the highest mean cost of hospitalization compared with all other groups, and this is supported by other evidence which showed that rural and remote locations is associated with poorer outcomes for certain health conditions. 30 A key study finding is that patients with CHF and COPD multimorbidity had the highest mean number of hospital Age reference group for multimorbidity is 40-59 years as the sample numbers were small (total n ¼ 46). admissions in the 3-year study period and associated hospital admission costs compared with the respective index conditions, which is supported by other studies. 31, 32 Our analyses also suggest that compared with the index COPD group, there was an estimated increase of £2000 in hospital admission costs for the multimorbid group. This emphasizes the importance of multimorbidity in association with increased healthcare utilization. It may partly explain that hospital costs were lower among Mosaic groups A and E (which comprises educated, young single people living in area of transient population), as these two groups showed the lowest prevalence of CHF and COPD multimorbidity.
Another key finding showed that hospital admission costs increased with age in the study population overall, our study group analyses showed that the cost of hospitalization for multimorbid patients decreased with older age. This could be explained by frequent attendance of older patients with shorter hospital stays 32 or might reflect the severity of multimorbidity among elderly patients who might be associated with higher mortality rates. 33 Younger patients, on the other hand, may have higher costs linked to increased intensity of treatments and investigations during the early course of multimorbidity.
What is already known in this topic
The use of Mosaic segmentation in public health is emerging. 3, 8, 9 These previous studies suggested that Mosaic may offer better opportunities to distinguish socio-economic differences combined with community behaviour characteristics, offering the potential for new approaches to healthcare interventions, with reduction in health inequality by targeted healthcare services. The impact of multimorbidity generally and CHF and COPD multimorbidity is also known. 18, 21 However, key gaps are the application of a multi-dimensional segmentation measure, such as Mosaic, especially in targeting high hospital admission cost groups who experience multiple chronic diseases at the same time.
What this study adds
This study is novel in linking multimorbidity and the Mosaic measure, and in understanding the influence of chronic disease multimorbidity and a population segmentation measure. By linking general practice registers to hospital data, it was possible to identify which group of population has the highest hospital admissions and costs for multimorbidity of COPD and CHF. This information allows healthcare systems to identify distinct sub-groups that may have similar needs, attitudes or behaviours and can be used to target groups in the best and most relevant ways to them.
5
A major strength of Mosaic is that it offers better understanding of population as it includes a wide range of marketing data, which adds value beyond the basic routine health and demographic information. 5 In addition to the demographic variables used by traditional methods of population classification such as age and gender, Mosaic segments populations by their lifestyles or behaviours that are most relevant to their interest. The ability of Mosaic to segment population in this way provides the potential intervention point for targeted healthcare delivery. In a review on the use of social marketing in public health, 34 a key characteristic was the notion of 'audience segmentation' within the marketing framework, which provides segments of people who share similar characteristics that make them more likely to respond equally to public health interventions. Although targeted interventions using Mosaic need to be developed, our study proposes that the combination of high-cost multimorbidity and Mosaic has the potential to provide better new interventions and points of preventative healthcare.
Public health departments are well versed in targeting deprived communities to reduce inequalities, from a practical perspective more research needs to be done to understand the association between different Mosaic groups and existing deprivation indices. Multimorbidity in addition is becoming a significant public health issue. Addressing barriers that might prevent attempts to adopt healthy lifestyles because of multimorbidity and understanding the communities through the use of Mosaic 19 should help to design tailored intervention programmes that can improve the public health of such groups and in turn reduces the costs and health inequity.
Limitations of this study
Whilst this was a large-scale study, the findings cover one area in England and further prospective research is required. The large dataset allowed for the comparisons of the CHF and COPD multimorbid group with respective index group. However, some of the findings may have occurred because of the small numbers of individual Mosaic groups, but part of the explanation for the lack of cost differences may be due to facts that there were wide variations in hospital admissions costs. Chronic diseases, such as CHF and COPD, are well recorded as a result of national quality frameworks. 35 This means that the registers allow for the construction of multimorbid investigations. Broader analysis of hospital admissions would include both the number of repeated and unplanned admissions as well as duration of stay, although the overall cost is a proxy measure for this.
Further work would also define the multi-dimensional approach of the Mosaic measure in relation to sociodemographic factors such as age and deprivation, and inclusion of data used to develop Mosaic categories. In our study, we adjusted for age and deprivation, to understand the specific influence of Mosaic and multimorbidity relationship. However, the inclusion of census data in Mosaic means that this approach may have resulted in an over adjustment, leading to conservative differences in cost estimations. So, the development of Mosaic in healthcare use requires further comparison with different socio-economic factors, deprivation indices and clinical populations.
Conclusions
CHF and COPD multimorbidity has significantly high healthcare costs compared with respective index groups and average hospital admission costs vary by Mosaic segmentation. The cost differences between Mosaic groups on average whilst large in magnitude were largely non-significant within the study population. However, the size of the cost differences for some of the Mosaic groups suggests that the incorporation of Mosaic segmentation and multimorbidity provides a novel basis for developing tailored healthcare intervention programmes targeting high-hospital-cost patients.
Supplementary data
Supplementary data are available at the Journal of Public Health online.
